These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27221203)

  • 1. VOC breath biomarkers in lung cancer.
    Saalberg Y; Wolff M
    Clin Chim Acta; 2016 Aug; 459():5-9. PubMed ID: 27221203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
    Zhou J; Huang ZA; Kumar U; Chen DDY
    Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
    Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
    Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
    Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
    PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A volatile biomarker in breath predicts lung cancer and pulmonary nodules.
    Phillips M; Bauer TL; Pass HI
    J Breath Res; 2019 Jun; 13(3):036013. PubMed ID: 31085817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
    Sun X; Shao K; Wang T
    Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
    Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
    Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
    Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
    Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
    Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
    Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers.
    Li Z; Shu J; Zhang P; Sun W; Yang B; Zhang H
    Cancer Biomark; 2016; 16(3):477-87. PubMed ID: 27062705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
    Oakley-Girvan I; Davis SW
    Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
    Hua Q; Zhu Y; Liu H
    Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study.
    Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y
    BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment, origin, and implementation of breath volatile cancer markers.
    Haick H; Broza YY; Mochalski P; Ruzsanyi V; Amann A
    Chem Soc Rev; 2014 Mar; 43(5):1423-49. PubMed ID: 24305596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
    Di Lena M; Porcelli F; Altomare DF
    Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.